Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY | BRISTOL MYERS SQUIBB CO | $122.80B | $45.19B | $18.65B | $7.96B | $3.78 | -4.15% | 15.91% | 24.34% | 72.15% | 2023-10-26 | |
HZNP | HORIZON THERAPEUTICS PUBLIC LTD CO | $26.47B | $3.64B | $901.54M | $438.00M | $1.92 | -4.42% | 27.71% | -42.86% | N/A | 2023-11-08 | |
GILD | GILEAD SCIENCES INC | $94.47B | $27.38B | $10.68B | $5.48B | $4.39 | -0.48% | 3.37% | 33.03% | 20.89% | 2023-10-25 | |
PFE | PFIZER INC | $189.82B | $77.94B | $28.47B | $21.47B | $3.81 | -23.04% | 7.92% | -27.01% | 0.05% | 2023-10-31 | |
SNY | SANOFI | $137.99B | $51.84B | $16.76B | $9.68B | $3.87 | 14.58% | 4.01% | 35.24% | 17.96% | 2023-10-27 | |
AZN | ASTRAZENECA PLC | $210.54B | $44.49B | $13.13B | $6.16B | $1.99 | 1.02% | 14.77% | N/A | 13.53% | 2023-11-09 | |
GSK | GSK PLC | $77.07B | $38.10B | $25.25B | $20.04B | $9.93 | 9.44% | -1.49% | 248.94% | 53.62% | 2023-11-01 | |
LLY | ELI LILLY & CO | $540.76B | $29.52B | $8.75B | $6.50B | $7.21 | 1.53% | 8.68% | 14.63% | N/A | 2023-11-02 | |
BIIB | BIOGEN INC | $37.73B | $9.97B | $3.71B | $2.66B | $18.48 | -6.23% | -4.98% | 31.62% | 5.48% | 2023-10-23 | |
AMGN | AMGEN INC | $145.20B | $26.58B | $14.82B | $7.98B | $14.93 | 0.75% | 2.77% | 26.20% | 31.90% | 2023-11-01 | |
ABBV | ABBVIE INC | $271.13B | $56.02B | $21.07B | $8.69B | $4.88 | -2.31% | 12.60% | -31.17% | 3.80% | 2023-10-26 | |
MRK | MERCK & CO INC | $272.30B | $58.31B | $10.14B | $3.11B | $1.22 | 2.00% | 7.16% | -81.40% | 19.06% | 2023-10-26 | |
AMRN | AMARIN CORP PLC | $388.33M | $346.27M | -$44.75M | -$38.30M | -$0.08 | -27.19% | 11.85% | N/A | N/A | 2023-10-27 | |
JNJ | JOHNSON & JOHNSON | $423.40B | $97.77B | $24.11B | $13.05B | $4.99 | 2.29% | 3.92% | -28.61% | 56.59% | 2023-10-17 | |
NVS | NOVARTIS AG | $214.23B | $53.07B | $22.06B | $7.65B | $3.62 | 0.54% | 4.82% | -64.79% | -9.46% | 2023-10-24 | |
OGN | ORGANON & CO | $4.84B | $6.17B | $1.60B | $754.00M | $2.96 | -2.94% | N/A | -32.11% | N/A | 2023-11-01 | |
GRFS | GRIFOLS SA | $6.63B | $6.59B | $1.31B | $226.39M | $0.34 | 15.08% | 4.47% | 3.77% | -22.28% | 2023-11-02 | |
SCLX | SCILEX HOLDING CO | $253.39M | $46.46M | -$46.30M | -$53.79M | -$0.44 | 48.33% | N/A | N/A | N/A |